Intrinsic Value of S&P & Nasdaq Contact Us

Kalaris Therapeutics Inc KLRS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.00
+257.8%

Kalaris Therapeutics Inc (KLRS) has 10 identified peers for comparison in the Healthcare sector. Peers include ARTV, CNTB, CNTX, IFRX, IMA, MGX and others.

KLRS has a market capitalization of $109.78M, compared to an average peer market cap of $184.61M.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message